The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Vitamin K Supplementation in Postmenopausal Women with Osteopenia (ECKO Trial): A Randomized Controlled Trial
Open accessAbstract
BACKGROUND: Vitamin K has been widely promoted as a supplement for decreasing bone loss in postmenopausal women, but the long-term benefits and potential harms are unknown. This study was conducted to determine whether daily high-dose vitamin K1 supplementation safely reduces bone loss, bone turnover, and fractures. METHODS AND FINDINGS: This single-center study was designed as a 2-y randomized, placebo-controlled, double-blind trial, extended for earlier participants for up to an additional 2 y because of interest in long-term safety and fractures. A total of 440 postmenopausal women with osteopenia were randomized to either 5 mg of vitamin K1 or placebo daily. Primary outcomes were changes in BMD at the lumbar spine and total hip at 2 y. Secondary outcomes included changes in BMD at other sites and other time points, bone turnover markers, height, fractures, adverse effects, and health-related quality of life. This study has a power of 90% to detect 3% differences in BMD between the two groups. The women in this study were vitamin D replete, with a mean serum 25-hydroxyvitamin D level of 77 nmol/l at baseline. Over 2 y, BMD decreased by -1.28% and -1.22% (p = 0.84) (difference of -0.06%; 95% confidence interval [CI] -0.67% to 0.54%) at the lumbar spine and -0.69% and -0.88% (p = 0.51) (difference of 0.19%; 95% CI -0.37% to 0.75%) at the total hip in the vitamin K and placebo groups, respectively. There were no significant differences in changes in BMD at any site between the two groups over the 2- to 4-y period. Daily vitamin K1 supplementation increased serum vitamin K1 levels by 10-fold, and decreased the percentage of undercarboxylated osteocalcin and total osteocalcin levels (bone formation marker). However, C-telopeptide levels (bone resorption marker) were not significantly different between the two groups. Fewer women in the vitamin K group had clinical fractures (nine versus 20, p = 0.04) and fewer had cancers (three versus 12, p = 0.02). Vitamin K supplements were well-tolerated over the 4-y period. There were no significant differences in adverse effects or health-related quality of life between the two groups. The study was not powered to examine fractures or cancers, and their numbers were small. CONCLUSIONS: Daily 5 mg of vitamin K1 supplementation for 2 to 4 y does not protect against age-related decline in BMD, but may protect against fractures and cancers in postmenopausal women with osteopenia. More studies are needed to further examine the effect of vitamin K on fractures and cancers. TRIAL REGISTRATION: ClinicalTrials.gov (#NCT00150969) and Current Controlled Trials (#ISRCTN61708241).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
Cockayne, S., Adamson, J., Lanham-New, S., Shearer, M. J., Gilbody, S., & Torgerson, D. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.12.1256 · Cited by 361 · cited 1×
“]. A recent meta-analysis of randomized controlled trials also showed that daily supplementation with vitamin K2 (45 mg of menaquinone 4) consistently reduces hip (odds ratio [OR] = 0.23, 95% CI 0.12 to 0.47), vertebral (OR = 0.40, 95% CI 0.25 to 0.65), and all nonvertebral fractures (OR = 0.19, 95% CI 0.11% to 0.35) [”
BackgroundInfluentialCirculating levels of vitamins K1 and K2 decreased in elderly women with hip fracture
Hodges, S. J., Akesson, K., Vergnaud, P., Obrant, K., & Prof. Delmas, P. D. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650081012 · Cited by 202
Effect of Vitamin K Supplementation on Bone Loss in Elderly Men and Women
Booth, S. L., Dallal, G., Shea, M. K., Gundberg, C., Peterson, J. W., & Dawson-Hughes, B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2490 · Cited by 177
Binkley, N., Harke, J., Krueger, D., Engelke, J., Vallarta-Ast, N., Gemar, D., Checovich, M., Chappell, R., & Suttie, J. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081254 · Cited by 163
Hodges, S. J., Pilkington, M. J., Stamp, T. C. B., Catterall, A., Shearer, M. J., Bitensky, L., & Chayen, J. (1991) · Bone · doi:10.1016/8756-3282(91)90027-g · Cited by 143 · cited 1×
“Although earlier epidemiologic studies showed low vitamin K1 intake and low plasma vitamin K1 levels to be associated with low bone mineral density (BMD) [3,4] and increased osteoporotic fracture risk in postmenopausal women [5–8], more recent randomized trials using low-dose vitamin K1 supplements showed conflicting…”
ResultCirculating vitamin K levels in patients with fractures
Bitensky, L., Hart, J., Catterall, A., Hodges, S., Pilkington, M., & Chayen, J. (1988) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.70b4.3403621 · Cited by 46
Cited by
Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites
Zini, A., Czerninski, R., & Sgan‐Cohen, H. D. (2010) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2009.00845.x · Cited by 265
Roles for Vitamin K Beyond Coagulation
Booth, S. L. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-080508-141217 · Cited by 256
Vitamin K to prevent fractures in older women: systematic review and economic evaluation
Stevenson, M., Lloyd-Jones, M., & Papaioannou, D. (2009) · Health Technology Assessment · doi:10.3310/hta13450 · Cited by 90
Guss, J. D., Taylor, E., Rouse, Z., Roubert, S., Higgins, C. H., Thomas, C. J., Baker, S. P., Vashishth, D., Donnelly, E., Shea, M. K., et al. (2019) · Bone · doi:10.1016/j.bone.2019.06.010 · Cited by 77
Metadata
- Authors
- Cheung, A. M., Tile, L., Lee, Y., Tomlinson, G., Hawker, G., Scher, J., Hu, H., Vieth, R., Thompson, L., Jamal, S., & Josse, R.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-10-14
- Volume
- 5
- Issue
- 10
- Pages
- e196
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2084800127
- Cited by
- 211
- References
- 7
- FWCI
- 14.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vitamin K Supplementation in Postmenopausal Women with Osteopenia (ECKO Trial): A Randomized Controlled Trial. https://app.cochat.ai/papers/10.1371/journal.pmed.0050196
- The paper
- Cheung, A. M., Tile, L., Lee, Y., Tomlinson, G., Hawker, G., Scher, J., Hu, H., Vieth, R., Thompson, L., Jamal, S., & Josse, R. (2008). Vitamin K Supplementation in Postmenopausal Women with Osteopenia (ECKO Trial): A Randomized Controlled Trial. PLoS Medicine. https://doi.org/10.1371/journal.pmed.0050196
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.